Elsevier
Journal of Hepatology
,  volume 82 ,  issue 2 ,  pages 174-188

ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH

Yasmine J Liu 1
, 
Masaki Kimura 2, 3
, 
Xiaoxu Li 1
, 
Jonathan Sulc 1
, 
Qi Wang 1
, 
Sandra Rodríguez-López 1
, 
Angelique M L Scantlebery 4
, 
Keno Strotjohann 1
, 
Hector Gallart-Ayala 5
, 
Archana Vijayakumar 6
, 
Robert P. Myers 6
, 
Julijana Ivanisevic 5
, 
Riekelt H. Houtkooper 7
, 
G Mani Subramanian 6
, 
Gayatri Subramanian 6
, 
T. Takebe 8, 9
, 
Johan Auwerx 10
1
 
2
 
3
 
4
 
5
 
6
 
OrsoBio, Inc., Menlo Park, CA, USA. | 
7
 
8
 
9
 
10
 
Publication type: Journal Article
Publication date: 2025-02-01
Elsevier
scimago Q1
wos Q1
SJR: 10.575
CiteScore: 48.5
Impact factor: 33.0
ISSN: 01688278, 16000641
Abstract
Recent findings reveal the importance of tryptophan-initiated de novo nicotinamide adenine dinucleotide (NAD
Found 
Found 

Top-30

Journals

1
2
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 2, 11.11%
Frontiers in Cell and Developmental Biology
2 publications, 11.11%
Cells
Cells, 1, 5.56%
Cells
1 publication, 5.56%
Pharmaceuticals
Pharmaceuticals, 1, 5.56%
Pharmaceuticals
1 publication, 5.56%
Drugs and Drug Candidates
Drugs and Drug Candidates, 1, 5.56%
Drugs and Drug Candidates
1 publication, 5.56%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 5.56%
International Journal of Molecular Sciences
1 publication, 5.56%
Life Sciences
Life Sciences, 1, 5.56%
Life Sciences
1 publication, 5.56%
Biomedicines
Biomedicines, 1, 5.56%
Biomedicines
1 publication, 5.56%
npj Metabolic Health and Disease
npj Metabolic Health and Disease, 1, 5.56%
npj Metabolic Health and Disease
1 publication, 5.56%
Scientific Reports
Scientific Reports, 1, 5.56%
Scientific Reports
1 publication, 5.56%
Cellular and Molecular Immunology
Cellular and Molecular Immunology, 1, 5.56%
Cellular and Molecular Immunology
1 publication, 5.56%
Hepatology Communications
Hepatology Communications, 1, 5.56%
Hepatology Communications
1 publication, 5.56%
Epigenetics
Epigenetics, 1, 5.56%
Epigenetics
1 publication, 5.56%
Molecular Biomedicine
Molecular Biomedicine, 1, 5.56%
Molecular Biomedicine
1 publication, 5.56%
GeroScience
GeroScience, 1, 5.56%
GeroScience
1 publication, 5.56%
Cell Reports Medicine
Cell Reports Medicine, 1, 5.56%
Cell Reports Medicine
1 publication, 5.56%
Redox Biology
Redox Biology, 1, 5.56%
Redox Biology
1 publication, 5.56%
1
2

Publishers

1
2
3
4
5
MDPI
MDPI, 5, 27.78%
MDPI
5 publications, 27.78%
Springer Nature
Springer Nature, 5, 27.78%
Springer Nature
5 publications, 27.78%
Elsevier
Elsevier, 3, 16.67%
Elsevier
3 publications, 16.67%
Frontiers Media S.A.
Frontiers Media S.A., 2, 11.11%
Frontiers Media S.A.
2 publications, 11.11%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 5.56%
Cold Spring Harbor Laboratory
1 publication, 5.56%
Ovid Technologies (Wolters Kluwer Health)
Ovid Technologies (Wolters Kluwer Health), 1, 5.56%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 5.56%
Taylor & Francis
Taylor & Francis, 1, 5.56%
Taylor & Francis
1 publication, 5.56%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
18
Share
Cite this
GOST |
Cite this
GOST Copy
Liu Y. J. et al. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH // Journal of Hepatology. 2025. Vol. 82. No. 2. pp. 174-188.
GOST all authors (up to 50) Copy
Liu Y. J., Kimura M., Li X., Sulc J., Wang Q., Rodríguez-López S., Scantlebery A. M. L., Strotjohann K., Gallart-Ayala H., Vijayakumar A., Myers R. P., Ivanisevic J., Houtkooper R. H., Subramanian G. M., Subramanian G., Takebe T., Auwerx J. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH // Journal of Hepatology. 2025. Vol. 82. No. 2. pp. 174-188.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jhep.2024.08.009
UR - https://linkinghub.elsevier.com/retrieve/pii/S016882782402484X
TI - ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH
T2 - Journal of Hepatology
AU - Liu, Yasmine J
AU - Kimura, Masaki
AU - Li, Xiaoxu
AU - Sulc, Jonathan
AU - Wang, Qi
AU - Rodríguez-López, Sandra
AU - Scantlebery, Angelique M L
AU - Strotjohann, Keno
AU - Gallart-Ayala, Hector
AU - Vijayakumar, Archana
AU - Myers, Robert P.
AU - Ivanisevic, Julijana
AU - Houtkooper, Riekelt H.
AU - Subramanian, G Mani
AU - Subramanian, Gayatri
AU - Takebe, T.
AU - Auwerx, Johan
PY - 2025
DA - 2025/02/01
PB - Elsevier
SP - 174-188
IS - 2
VL - 82
PMID - 39181211
SN - 0168-8278
SN - 1600-0641
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Liu,
author = {Yasmine J Liu and Masaki Kimura and Xiaoxu Li and Jonathan Sulc and Qi Wang and Sandra Rodríguez-López and Angelique M L Scantlebery and Keno Strotjohann and Hector Gallart-Ayala and Archana Vijayakumar and Robert P. Myers and Julijana Ivanisevic and Riekelt H. Houtkooper and G Mani Subramanian and Gayatri Subramanian and T. Takebe and Johan Auwerx},
title = {ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH},
journal = {Journal of Hepatology},
year = {2025},
volume = {82},
publisher = {Elsevier},
month = {feb},
url = {https://linkinghub.elsevier.com/retrieve/pii/S016882782402484X},
number = {2},
pages = {174--188},
doi = {10.1016/j.jhep.2024.08.009}
}
MLA
Cite this
MLA Copy
Liu, Yasmine J., et al. “ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH.” Journal of Hepatology, vol. 82, no. 2, Feb. 2025, pp. 174-188. https://linkinghub.elsevier.com/retrieve/pii/S016882782402484X.